Literature DB >> 12552590

Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors.

Sai-Mei Hou1, Charlotta Ryk, Annamaria Kannio, Sabrina Angelini, Susann Fält, Fredrik Nyberg, Kirsti Husgafvel-Pursiainen.   

Abstract

The DNA repair proteins XPD and XRCC1 are involved in the nucleotide and base excision repair of DNA lesions induced by many tobacco and environmental carcinogens. Common variant alleles at the XPD (312Asn, 751Gln) and XRCC1 (399Gln) loci have been identified and associated with increased risk for lung cancer. We therefore investigated a possible effect of these variant alleles on the frequency and spectrum of p53 mutations in the tumors of 97 Swedish lung cancer patients (56 never-smokers and 41 age-, gender-, and hospital-matched ever-smokers). The p53 gene was mutated in 4 never-smokers (7%) and 11 ever-smokers (27%). Smoking-related transversion-type mutations predominated over transitions among smokers (8:3), but not among never-smokers (1:3). None of the variant alleles altered the overall frequency of p53 mutation. Transversions, however, were marginally increased among patients with at least one XPD variant allele compared with patients who were wild-type homozygotes (73% vs. 25% for the Asp312Asn polymorphism, P = 0.095; 78% vs. 33% for Lys751Gln, P = 0.085). Five of six women or six of seven smokers who carried at least one XPD 751Gln allele had p53 transversion. The XRCC1 variant allele did not show any effect on the p53 mutation. We conclude that the XPD variant alleles may be associated with an increased frequency of smoking-related p53 mutations in lung tumors, presumably due to reduced DNA repair proficiency. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552590     DOI: 10.1002/em.10128

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  10 in total

1.  The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers.

Authors:  Charlotta Ryk; Sai-Mei Hou; Göran Pershagen; N Peter Wiklund; Fredrik Nyberg; Petra J de Verdier
Journal:  Tumour Biol       Date:  2014-01-10

2.  XRCC1 polymorphisms and lung cancer risk in Caucasian populations: a meta-analysis.

Authors:  Liangdong Chen; Deqiang Zhuo; Jiakuan Chen; Hongyin Yuan
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.

Authors:  Ming Yin; Zhongxing Liao; Zhensheng Liu; Li-E Wang; Daniel Gomez; Ritsuko Komaki; Qingyi Wei
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-21       Impact factor: 7.038

4.  Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.

Authors:  Leelakumari Sreeja; Volga S Syamala; Vani Syamala; Sreedharan Hariharan; Praveenkumar B Raveendran; R V Vijayalekshmi; Jayaprakash Madhavan; Ravindran Ankathil
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-19       Impact factor: 4.553

5.  Polymorphisms in apoptosis-related genes and TP53 mutations in non-small cell lung cancer.

Authors:  Eun Young Bae; Eun Jin Lee; Hyo-Gyoung Kang; Shin Yup Lee; Gwang Jin; Won Kee Lee; Jin Eun Choi; Hyo-Sung Jeon; Jeong Ok Lim; Eung Bae Lee; Jae Yong Park
Journal:  J Korean Med Sci       Date:  2011-10-27       Impact factor: 2.153

6.  Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays.

Authors:  William W Au; Salama A Salama; Carlos H Sierra-Torres
Journal:  Environ Health Perspect       Date:  2003-11       Impact factor: 9.031

7.  What's your poison? Impact of individual repair capacity on the outcomes of genotoxic therapies in cancer. Part II - information content and validity of biomarkers for individual repair capacity in the assessment of outcomes of anticancer therapy.

Authors:  Rumena Petkova; Pavlina Chelenkova; Elena Georgieva; Stoian Chakarov
Journal:  Biotechnol Biotechnol Equip       Date:  2014-01-02       Impact factor: 1.632

8.  Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia.

Authors:  Eng-Zhuan Ban; Munn-Sann Lye; Pei Pei Chong; Yoke-Yeow Yap; Siew Ying Crystale Lim; Hejar Abdul Rahman
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

9.  XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk.

Authors:  Xi Dai Long; Yun Ma; Yun Feng Zhou; Jin Guang Yao; Fu Zhi Ban; Yong Zhi Huang; Bing Cheng Huang
Journal:  BMC Cancer       Date:  2009-11-17       Impact factor: 4.430

10.  A comprehensive meta-analysis and a case-control study give insights into genetic susceptibility of lung cancer and subgroups.

Authors:  Debmalya Sengupta; Souradeep Banerjee; Pramiti Mukhopadhyay; Ritabrata Mitra; Tamohan Chaudhuri; Abhijit Sarkar; Gautam Bhattacharjee; Somsubhra Nath; Susanta Roychoudhury; Samsiddhi Bhattacharjee; Mainak Sengupta
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.